Fluvoxamine trial cuts long COVID fatigue in 399 adults, improving quality of life
A randomized study shows fluvoxamine, a low-cost antidepressant, meaningfully eases disabling long COVID fatigue versus placebo.

Loading briefings
Pulling the latest in this topic…
Research, space, health, climate, discovery
510 briefings briefings in Science
A randomized study shows fluvoxamine, a low-cost antidepressant, meaningfully eases disabling long COVID fatigue versus placebo.
The biennial Environmental Performance Index shows sustainability gains, then quietly warns progress is slowing on net-zero pathways.
Otto von Guericke University Magdeburg chemists produced lab-made precursors to Neosorangicin A, potentially speeding future antibiotic-resistance countermeasures.
A new paper argues historians misread Roman farm female managers, overlooking their role in wine, oil, and profits.
A lab-made super-strong, stretchable adhesive that is strong enough to hold, yet wipes away completely.
A new study shows how cells recover splicing function under heat stress, flipping the usual “shutdown” narrative.
The 10-meter prototype landed softly after a planned 15-meter crawl, teeing up Japan’s CALLISTO single-stage reuse push.
New research links popular sugar substitutes to faster memory and thinking decline, with bigger effects for under 60 and diabetes.
A well-funded US Space Force push is turning SpaceX’s launch cadence into a national-security business line.
A 2024 New Jersey fall helped scientists trace preserved prebiotic molecules to ancient salty brines in a primitive body.
The study finds time-restricted eating beats usual longer schedules, and early fasting may better preserve fat loss.
These accidental sound swaps clarify the brain circuitry behind speech, turning common errors into a real research signal.